2,5-hexanedione has been researched along with 2,3-hexanedione in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwasaki, K; Tsuruta, H | 1 |
Coleman, MD; Griffiths, HR; Zilz, TR | 1 |
Coleman, MD; Griffiths, HR; Woehrling, EK; Zilz, TR | 1 |
3 other study(ies) available for 2,5-hexanedione and 2,3-hexanedione
Article | Year |
---|---|
Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione.
Topics: Animals; Gas Chromatography-Mass Spectrometry; Hexanes; Hexanones; Ketones; Kinetics; Male; Nervous System Diseases; Rats; Rats, Inbred Strains; Tissue Distribution | 1984 |
Apoptotic and necrotic effects of hexanedione derivatives on the human neuroblastoma line SK-N-SH.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Food Additives; Formazans; Hexanones; Humans; Isomerism; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Tetrazolium Salts | 2007 |
A comparison of the apoptotic and cytotoxic effects of hexanedione derivatives on human non-neuronal lines and the neuroblastoma line SH-SY5Y.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Formazans; Hexanones; Humans; Isomerism; Neuroblastoma; Neurons; Tetrazolium Salts | 2008 |